Off-label applications of omalizumab: Current insights and perspectives☆
Aleksandra Jaromin, Aleksandra Wardzyńska · 2025
Read Off-label applications of omalizumab: Current insights and perspectives☆ by Aleksandra Jaromin, Aleksandra Wardzyńska (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12757523.txt.
Description
Aleksandra Jaromin and Aleksandra Wardzyńska review off label uses of an allergy drug in a 2025 paper. The drug, omalizumab, traps a key allergy antibody in the blood and calms allergic chains. It has been sold for twenty years with a strong safety record, approved for asthma, hives, and sinus growths in Europe.
Reports in the wider record stretch much further. Doctors have tried it for eye allergy, food allergy, drug reactions, a lung mold illness, and as a helper for allergy shots, among other uses. The review sorts what is known for each use and where proof is thin. The authors see the drug as the most flexible tool of its kind for allergy care.
Catalog record
| CREATOR | Aleksandra Jaromin, Aleksandra Wardzyńska |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 36 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |